Generate Biomedicines Inc. is a biotechnology company pioneering the field of generative biology to create breakthrough medicines. Founded by Flagship Pioneering in 2018, the company operates at the intersection of machine learning, biological engineering, and high-throughput experimental biology. Unlike traditional drug discovery, which often relies on screening existing libraries or natural molecules, Generate Biomedicines uses its proprietary 'Generate Platform' to programmatically design de novo protein therapeutics. The Generate Platform is built upon a sophisticated computational engine that has learned the fundamental principles of protein structure and function by analyzing vast datasets of biological sequences. This allows the company to design proteins with specific, desired characteristics—such as binding affinity, stability, and potency—across various modalities, including antibodies, peptides, and enzymes. By treating drug discovery as an engineering challenge, the company aims to increase the probability of clinical success and drastically shorten development timelines. Generate Biomedicines' therapeutic pipeline spans multiple high-impact areas, including oncology, immunology, and infectious diseases. The company is led by CEO Mike Nally and a team of experts in both computational science and drug development. Through its innovative approach, Generate Biomedicines seeks to transform the pharmaceutical industry by moving from a model of serendipitous discovery to one of intentional, AI-driven design, ultimately delivering more effective treatments to patients worldwide.
The sum of declared dividends issued by a company for every ordinary share outstanding.
Dividend Yield is a financial ratio that shows how much a company pays out in dividends each year relative to its share price in the last twelve months. In the absence of any capital gains, the dividend yield is the return on investment for a stock.
It is another way that companies have to remunerate their shareholders, being an alternative to dividends. Shows the % of repurchases per share made in the last 12 months in relation to the share price.
Sum of Dividend Yield and BuyBack Yield to show the total return that the shareholder received in the last 12 months in relation to the share price.
The dividend payout ratio is the ratio of the total amount of dividends paid out to shareholders relative to the net income of the company. It is the percentage of earnings paid to shareholders via dividends.
Retained earnings (RE) are the amount of net income left over for the business after it has paid out dividends to its shareholders and are an important variable for assessing a company's financial health because it shows the net income that a company has saved over time, and therefore has the ability to reinvest in the business or distribute to shareholders.
...and much more!